Clinical trial
Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
NCT00069186 · The Avicena Group, Industry · Unknown status
Key facts
| NCT number | NCT00069186 |
|---|---|
| Title | Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis |
| Official title | A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis |
| Lead sponsor | The Avicena Group, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis (ALS) |
| Intervention type | Drug |
| Interventions | Creatine Monohydrate |
| Enrollment | 107 |
| Start date | Jun 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Sep 23, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: